Pirfenidone in Treating Patients With Fibrosis Caused by Radiation Therapy for Cancer

NCT00020631 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

NIH

Sponsor class

Conditions

Radiation Fibrosis

Interventions

DRUG: pirfenidone

Sponsor

National Cancer Institute (NCI)